Arterial Stiffness in Mild Primary Hyperparathyroidism
The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Abstract
When primary hyperparathyroidism was a more symptomatic disease, it was often associated with increased cardiovascular risk. As the clinical manifestations of the disease have changed to a milder, more asymptomatic disorder, investigation is shifting to more subtle cardiovascular abnormalities. We measured arterial stiffness in 39 patients with mild primary hyperparathyroidism [serum calcium, 2.66 +/- 0.2 mmol/liter (10.7 +/- 0.6 mg/dl); PTH, 21.7 +/- 9.5 pmol/liter (89 +/- 39 pg/ml)] and in 134 controls. Arterial stiffness was measured mathematically at the radial artery with a noninvasive device as the "augmentation index" (AIx). The AIx measures the difference between the second and first systolic peaks in the pressure waveform and correlates with increased cardiovascular risk. When physiological variables affecting augmentation index and potentially confounding cardiovascular risk factors (age, gender, heart rate, height, blood pressure, diabetes mellitus, smoking, and hyperlipidemia) were adjusted for, primary hyperparathyroidism was an independent predictor of increased augmentation index (B = 3.37; P < 0.03). A matched-pair analysis showed that 15% of the variance in AIx was uniquely accounted for by the presence of primary hyperparathyroidism. The presence of primary hyperparathyroidism was a stronger predictor of elevated AIx than age, gender, smoking, hypertension, hyperlipidemia, or diabetes mellitus. AIx was also directly correlated with evidence of more active parathyroid disease, including higher PTH levels (r = +0.42; P < 0.05) and lower bone mineral density at the distal one-third radius (r = -0.33; P < 0.05). The diagnosis of primary hyperparathyroidism was therefore an independent predictor of increased AIx, an early measure of arterial stiffness, and the increase was associated with evidence of more active parathyroid disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
O'Leary, D. H., Polak, J. F., Kronmal, R. A., Manolio, T. A., Burke, G. L., & Wolfson, S. K. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901073400103 · Cited by 4,685
Pauca, A. L., O’Rourke, M. F., & Kon, N. D. (2001) · Hypertension · doi:10.1161/hy1001.096106 · Cited by 1,179
Effects of age and aerobic capacity on arterial stiffness in healthy adults.
Vaitkevicius, P. V., Fleg, J. L., Engel, J. H., O'Connor, F. C., Wright, J. G., Lakatta, L. E., Yin, F. C., & Lakatta, E. G. (1993) · Circulation · doi:10.1161/01.cir.88.4.1456 · Cited by 1,083 · cited 2×
“In addition, a younger control group was used, in whom the AIx might be lower simply as a function of age (11).”
MethodResultArterial stiffness, wave reflections, and the risk of coronary artery disease
Weber, T., Auer, J., O’Rourke, M. F., Kvas, E., Lassnig, E., Berent, R., & Eber, B. (2004) · Circulation · doi:10.1161/01.cir.0000105767.94169.e3 · Cited by 1,081
Reproducibility of pulse wave velocity and augmentation index measured by pulse wave analysis
Wilkinson, I. B., Fuchs, S. A., Jansen, I. M., Spratt, J. C., Murray, G. D., Cockcroft, J. R., & Webb, D. J. (1998) · Journal of Hypertension · doi:10.1097/00004872-199816121-00033 · Cited by 924 · cited 1×
“Reproducibility of the AIx using the SphygmoCor apparatus was determined as described previously (22).”
MethodKARAMANOGLU, M., O'ROURKE, M. F., AVOLIO, A. P., & KELLY, R. P. (1993) · European Heart Journal · doi:10.1093/eurheartj/14.2.160 · Cited by 873
Salomaa, V., Riley, W., Kark, J. D., Nardo, C., & Folsom, A. R. (1995) · Circulation · doi:10.1161/01.cir.91.5.1432 · Cited by 582
Arterial Stiffness Increases With Deteriorating Glucose Tolerance Status: The Hoorn Study
Henry, R. M. A., Kostense, P. J., Spijkerman, A. M. W., Dekker, J. M., Nijpels, G., Heine, R. J., Kamp, O., Westerhof, N., Bouter, L. M., & Stehouwer, C. D. A. (2003) · Circulation · doi:10.1161/01.cir.0000065222.34933.fc · Cited by 471 · cited 1×
“Increased AIx occurs in diabetes mellitus and hypercholesterolemia, probably as a result of alterations in the arterial wall elastin and collagen (14, 15).”
BackgroundIncreased central pulse pressure and augmentation index in subjects with hypercholesterolemia
Wilkinson, I. B., Prasad, K., Hall, I. R., Thomas, A., MacCallum, H., Webb, D. J., Frenneaux, M. P., & Cockcroft, J. R. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)01723-0 · Cited by 448 · cited 1×
“Increased AIx occurs in diabetes mellitus and hypercholesterolemia, probably as a result of alterations in the arterial wall elastin and collagen (14, 15).”
BackgroundKelly, R. P., Millasseau, S. C., Ritter, J. M., & Chowienczyk, P. J. (2001) · Hypertension · doi:10.1161/01.hyp.37.6.1429 · Cited by 393 · cited 2×
“Other factors that can influence AIx include heart rate and height (9, 10).”
Background
Cited by
Items 101–145 of 145
Inactivation of Parathyroid Hormone: Perspectives of Drug Discovery to Combating Hyperparathyroidism
Kumar, A., & Balbach, J. (2021) · Current Molecular Pharmacology · doi:10.2174/1874467214666210126112839 · Cited by 4
Nontraditional Aspects of Sporadic Primary Hyperparathyroidism
Walker, M. D., & Silverberg, S. J. (2021) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2021.07.007 · Cited by 4
Self-citationBuiles-Montaño, C. E. (2017) · Medicina y Laboratorio · doi:10.36384/01232576.59 · Cited by 4
Hypertension in thyroid disease and primary hyperparathyroidism
Szwarcbard, N., & Topliss, D. J. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-96120-2.00005-4 · Cited by 4
Kim, J., Nam, J. S., Kim, H., Lee, H. S., & Lee, J. E. (2020) · International Journal for Vitamin and Nutrition Research · doi:10.1024/0300-9831/a000642 · Cited by 3
Physiological Actions of PTH and PTHrP IV
Towler, D. A. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-397166-1.00012-6 · Cited by 3
HYPERPARATIROSIS AND CARDIOVASCULAR SYSTEM PATHOLOGY
Voronenko, I. V., Al, S., Rozhinskaya, L. Y., & Mel'nichenko, G. A. (2006) · Osteoporosis and Bone Diseases · doi:10.14341/osteo2006233-41 · Cited by 3
Silverberg, S. J., & Bilezikian, J. P. (2011) · doi:10.1093/med/9780199235292.003.0419 · Cited by 3
Self-citationSilverberg, S. J., & Bilezikian, J. P. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-18907-1.00063-9 · Cited by 2
Self-citationImpact of kidney function on stiffness of small conduit arteries in hypertension and obesity
Moriconi, D., Nannipieri, M., Badhwar, S., Taddei, S., Boutouyrie, P., & Bruno, R. M. (2025) · Journal of Hypertension · doi:10.1097/hjh.0000000000003957 · Cited by 2
“Informed consent was obtained”
Primary Hyperparathyroidism in Men
Marcocci, C., Cianferotti, L., Silverberg, S. J., & Bilezikian, J. P. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-374602-3.00039-0 · Cited by 2
Self-citationDiagnosis and management of primary hyperparathyroidism
Cusano, N. E., & Bilezikian, J. P. (2013) · Journal of clinical outcomes management · Cited by 2
Self-citationParathyroids, bone and mineral metabolism
Green, D. E., & Epstein, S. (2006) · Current Opinion in Endocrinology & Diabetes · doi:10.1097/med.0b013e32801061e1 · Cited by 2
Chandran, M. (2018) · Springer eBooks · doi:10.1007/978-981-10-1124-5_18 · Cited by 2
Neurovascular Consequences of Systemic Disease: Lupus and Primary Hyperparathyroidism
Sum, M., Kapoor, T. M., & Walker, M. D. (2020) · Springer eBooks · doi:10.1007/978-3-030-49586-2_14 · Cited by 2
Bilezikian, J. P. (2022) · doi:10.1093/med/9780198870197.003.0083 · Cited by 2
Self-citationPerrier, N. D., Weaver, S., Gantela, S., & Rao, D. S. (2011) · Springer eBooks · doi:10.1007/978-1-4614-2164-1_8 · Cited by 1
The Role of PTHrP in Vascular Smooth Muscle
Towler, D. A. (2014) · Clinical Reviews in Bone and Mineral Metabolism · doi:10.1007/s12018-014-9169-2 · Cited by 1
“The vasodilatory actions of PTHrP and PTH are initially paradoxical when viewed against the backdrop of the hypertension and vascular disease arising in settings of primary hyperparathyroidism (HPT) [33–41].”
BackgroundCardiovascular actions of parathyroid hormone/parathyroid hormone–related protein signaling
Mirfakhraee, S., & Towler, D. A. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-814841-9.00026-9 · Cited by 1
Habib, Z. A., & Camacho, P. M. (2010) · Expert Review of Endocrinology & Metabolism · doi:10.1586/eem.09.81 · Cited by 1
New Concepts for Primary and Secondary Hyperparathyroidism
Beige, J., & Lamesch, P. (2012) · Springer eBooks · doi:10.1007/978-1-4419-5550-0_5 · Cited by 1
“Furthermore, reduction of blood pressure, left ventricular hypertrophy after PTX have been reported [ 48– 53 ] .”
BackgroundSilverberg, S. J., & Bilezikian, J. P. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-5583-9.00062-9 · Cited by 1
Self-citationUnderstanding and Managing Primary Hyperparathyroidism –Anything New?
(2010) · touchREVIEWS in Endocrinology · doi:10.17925/ee.2010.06.02.55 · Cited by 1
Actions of Parathyroid Hormone on the Vasculature and Cardiovascular System
Fitzpatrick, L. A., Bilezikian, J. P., & Silverberg, S. J. (2008) · Elsevier eBooks · doi:10.1016/b978-0-12-373884-4.00002-1 · Cited by 1
Self-citationMetabolic Disturbances in Relation to Serum Calcium and Primary Hyperparathyroidism
Hagström, E. (2006) · Uppsala University Publications (Uppsala University) · Cited by 2
Kamani, F., Mohammadi, S., Tavassoli, S., Hessami, R., & پیروی, ح. ا. (2011) · Bushehr University of Medical Sciences Repository (Bushehr University of Medical Sciences)
Reza, A. (2012) · InTech eBooks · doi:10.5772/31494
“(Ca×P) and vitamin D are inconsistent[58-62].”
Approach to Parathyroid Disorders
Bilezikian, J. P. (2013) · Primer on the metabolic bone diseases and disorders of mineral metabolism · doi:10.1002/9781118453926.ch67
Self-citationMethodological studies applying new techniques for evaluation of arterial function
Ring, M. (2014) · Figshare
Manifestaciones clínicas y formas asintomáticas del hiperparatiroidismo primario
Sáez, J. M. G. (2009) · Endocrinología y Nutrición · doi:10.1016/s1575-0922(09)70850-2
Nonadrenal Endocrine Hypertension
Silva, J. E. (2007) · Elsevier eBooks · doi:10.1016/b978-0-323-03961-1.50076-3
Rossi, G. P., Seccia, T. M., & Accademico, A. (2014)
M1ld Asymptomat1c Hyperparathyro1d1sm
Feldt‐Rasmussen, B., & Güldiken, S. (2010)
Renal excretion function in primary hyperparathyroidism: cardio-renal syndrome
Mirnaya, S. S., Сергеевна, М. И., Dobreva, E. A., & Mokrysheva, N. G. (2021) · Nephrology (Saint-Petersburg) · doi:10.36485/1561-6274-2021-25-1-59-69
Subtle Variants of Hyperparathyroidism: Normocalcemic Hyperparathyroidism
Ranganath, R., Moseley, K. F., & Tufano, R. P. (2021) · Springer eBooks · doi:10.1007/978-3-030-73951-5_9
Hypertension, Vitamin D Deficiency, and Calcium Metabolism
Ullah, M. I., Koch, C. A., & Tangpricha, V. (2012) · Humana Press eBooks · doi:10.1007/978-1-60761-548-4_10
(2007) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0b013e3282f315ef
Harbuz-Miller, I., Woodman, R., & Lastra, G. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.95896-3
(2006) · Current Opinion in Endocrinology & Diabetes · doi:10.1097/med.0b013e328011e882
La progressione della malattia renale cronica
Manfellotto, D., & Pinna, G. (2023) · Italian Journal of Medicine · doi:10.4081/itjm.q.2023.3
Huber, A., Pasquier, T., Demarchi, M. S., Sadowski, S. M., Berchtold, L., Triponez, F., de Seigneux, S., & Ponte, B. (2025) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaf687
Kaynak, H., Kocabaş, M., Baylan, F. A., Öztürk, Y., & Karaköse, M. (2026) · Sakarya Medical Journal · doi:10.31832/smj.1820370
Siqueira, R. S. V., Konze, V. S., Andrade, B. M. S., Lima, A. M. B., & Bandeira, F. (2026) · Research Square · doi:10.21203/rs.3.rs-11106084/v1
George, J. A. (2014) · University of the Witwatersrand, Johannesburg Institutional Repository on DSpace (University of the Witwatersrand, Johannesburg) · Cited by 2
Bg, I., & Николаевна, С. О. (2012) · Annals of the Russian academy of medical sciences · doi:10.15690/vramn.v67i11.472
Metadata
- Authors
- Rubin, M. R., Maurer, M. S., McMahon, D. J., Bilezikian, J. P., & Silverberg, S. J.
- Affiliations
- Columbia University (US)
- Corresponding author
- Silverberg, Shonni J.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2005-06
- Volume
- 90
- Issue
- 6
- Pages
- 3326-3330
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2111131646
- Cited by
- 145
- References
- 36
- Citations by year
- 2026: 2 · 2025: 3 · 2024: 2 · 2023: 3 · 2022: 4 · 2021: 6 · 2020: 6 · 2019: 6 · 2018: 8 · 2017: 7 · 2016: 1 · 2015: 9 · 2014: 9 · 2013: 14 · 2012: 20
- FWCI
- 4.33
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK032333, R01DK066329)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Disease Prevention
- Health Sciences › Medicine › Nephrology › Parathyroid Disorders and Treatments
- Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
- Keywords
- primary hyperparathyroidism, arterial stiffness, augmentation index, cardiovascular risk, parathyroid hormone, bone mineral density, radial artery
- MeSH terms
- Aged, Blood Pressure, Brachial Artery, Female, Heart Rate, Humans, Hyperparathyroidism, Male, Middle Aged, Pulse, Reference Values, Regression Analysis, Systole
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.